Internet Sales of Dermocosmetics: the Paris Court of Appeal Refers the Case to the Court of Justice of the European Communities
6th November 2009 CASTRES, France, November 6 /PRNewswire/ -- The case opposing the French Competition Authority and Pierre Fabre
Dermocosmetics (PFDC) came before the Paris Court of Appeal on Thursday, 29
October...
Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
6th November 2009 PARIS, November 6 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the
discovery and development of novel antibiotics designed to overcome the
significant global problem of...
Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced
5th November 2009 PEMBROKE, Bermuda, November 5 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today reported
net income of $200.6 million, or $3.83 per diluted share, for the third
quarter...
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
5th November 2009 AURORA, Ontario, November 5 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced today
that its Phase II trial of Topical Interferon Alpha-2b for the treatment...
Novel Laser Coding Technology for Pharmaceutical Glass Containers
5th November 2009 ST GALLEN, Switzerland, November 5 /PRNewswire/ -- A completely new innovative laser-coding system enables glass containers
for parenteral use to be clearly coded at the glass syringe manufacturer...
Sirius Genomics received NRC-IRAP Funding for Continued Development of a Sepsis Companion Diagnostic
5th November 2009 VANCOUVER, November 5 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced
today that it has signed its first Contribution Agreement with the National
Research...
Breast Enlargement Day Case Operations Increase by 235 per Cent
5th November 2009 LONDON, November 5 /PRNewswire/ -- Breast enlargement operations performed as day case operations have
soared in the past 15 years, seeing a whopping 235 per cent increase, UK
cosmetic surgeons...
Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
5th November 2009 NOVATO, California, November 5 /PRNewswire/ -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP), today announced that data
from a clinical trial of NGX426, the Company's orally administered
non-opioid,...
Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
4th November 2009 PETERSBURG, Virginia, November 4 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: STSI) announced today that the company
plans to introduce the CigRx(TM) nutraceutical product developed by...
Bodycare's Response To Poppies
4th November 2009 CHORLEY, England, November 4 /PRNewswire/ -- As a business we have a strongly multi-cultural heritage and we wish to
ensure that we never, even inadvertently, discriminate against any of our
members...
Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas
4th November 2009 BOZEN, Italy, November 4 /PRNewswire/ -- Health Robotics today announced the worldwide presentation and launch of
its new i.v.SOFT Workflow Engine at the American Society of Health-System...
Poverty and Discrimination on the Rise for Disabled People: Leonard Cheshire Disability Report
4th November 2009 LONDON, November 4 /PRNewswire/ -- Poverty and discrimination experienced by disabled people is on the rise,
according to a survey conducted by Leonard Cheshire Disability.
In its annual...
Ortho Clinical Diagnostics Launches First-of-its-kind Remote Monitoring Center in Europe
4th November 2009 PARIS, November 4 /PRNewswire/ -- Ortho Clinical Diagnostics (OCD) today announced the launch of a
first-of-its-kind 24-7 central command center in Strasbourg, France, that
continuously tracks the...
Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
4th November 2009 RICHMOND, Virginia, November 4 /PRNewswire/ -- Filtrona Porous Technologies, manufacturer of custom fluid handling fiber
and foam components for the medical device and healthcare industry, and...
FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease
4th November 2009 CAMBRIDGE, Massachusetts, November 4 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that the United States Food and
Drug...
ThromboGenics NV - Q3 2009 Business Update
4th November 2009 LEUVEN, Belgium, November 4 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical
company focused on innovative medicines for eye disease, vascular disease and
cancer, is...
Obituary: Professor James Boyer Brown
4th November 2009 MELBOURNE, Australia, November 4 /PRNewswire/ -- The scientific and medical community mourns the loss of our esteemed
colleague and good friend Emeritus Professor James Boyer Brown AM, MSc (NZ),
PhD...
Allied World's Eugene Raitt Elected 2010 Chairman of the Board for the Direct Marketing Association
4th November 2009 PEMBROKE, Bermuda, November 4 /PRNewswire/ -- Allied World Assurance Company, Ltd, a member company of Allied World
Assurance Company Holdings, Ltd (NYSE: AWH) today announced that Eugene
Raitt,...
MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
3rd November 2009 WILMINGTON, Delaware, November 3 /PRNewswire/ -- The new market research report, 'Global Stem Cell and Advanced
Technologies Market' (2009 - 2014)', published by...
Christmas Shopping 2009: Will the British be Deterred by Swine Flu?
3rd November 2009 LONDON, November 3 /PRNewswire/ -- Twenga, the comprehensive shopping search engine, today reveals further
results from its annual Christmas Spending Survey. The company asked over
3000 Europeans...
Astellas Pharma Europe Announces the International Foundation for Dermatology a Winner of the Changing Tomorrow 2009 Awards
3rd November 2009 STAINES, England, November 3 /PRNewswire/ -- Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas
Pharma Inc, one of the world's top 20 pharmaceutical companies, can today...
Combined Pharma Event Visitor Numbers 5% Ahead of 2008 Frankfurt Record
2nd November 2009 MAARSSEN, Netherlands, November 2 /PRNewswire/ -- Returning confidence across the global pharma ingredients and services
sector was marked by the buoyant CPhI Worldwide and co-located exhibitions...
Master of Malt Launches 'Whisky 4 Movember' - a Secret, Charity Bottling
2nd November 2009 CROWBOROUGH, England, November 2 /PRNewswire/ -- Movember is a global charity raising awareness and funds for men's health
issues whilst having a spot of fun along the way. Every November, teams...
Abbott's XIENCE PRIME(TM) and XIENCE V(R) Receive Indications in Europe for Treatment of Patients with Diabetes
2nd November 2009 BRUSSELS, November 2 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that both the XIENCE PRIME(TM)
Everolimus Eluting Coronary Stent System(1) and the XIENCE V(R) Everolimus
Eluting Coronary...
Bicycle Therapeutics and Pepscan Enter Into Partnership to Apply Constrained Peptide Technology in the Development of Novel Biotherapeutics
2nd November 2009 CAMBRIDGE, England and LELYSTAD, The Netherlands, November 2 /PRNewswire/ -- Bicycle Therapeutics has obtained a global license from Pepscan to
utilize its proprietary constrained peptide chemistry...
Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
2nd November 2009 NEW BRUNSWICK, New Jersey, November 2 /PRNewswire/ -- In a joint statement, Czura Thornton's founders Tony Czura and Nick
Thornton said: "We are delighted to augment our Life Sciences Group...
AMD LASERS Obtains Certification in ISO 13485
2nd November 2009 INDIANAPOLIS, November 2 /PRNewswire/ -- AMD LASERS today announced it has attained International Organization for
Standardization (ISO) 13485:2003 certification of its medical device...
Media Advisory - Oncolytics Biotech(R) Inc. to Present at BIO-Europe 2009
2nd November 2009 CALGARY, Canada, November 2 /PRNewswire/ -- Dr. Matt Coffey, Chief Operating Officer of Oncolytics Biotech Inc. (
TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company
at the...
Correction: The Advisory Council on the Misuse of Drugs and the Royal Pharmaceutical Society
2nd November 2009 LONDON, November 2 /PRNewswire/ -- Media reports over the weekend suggested that Marion Walker FRPharm, who
has resigned from the Advisory Council on the Misuse of Drugs (ACMD), was
representing the...
New Shire Board Member
2nd November 2009 DUBLIN, Ireland, November 2 /PRNewswire/ -- The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY) announces
that Mr David Stout joined the Board as a Non Executive Director with effect
from...
Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
2nd November 2009 COPENHAGEN, November 2 /PRNewswire/ -- Nuevolution A/S today announced that it has received a milestone payment
derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.
The...
InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways
2nd November 2009 UTRECHT, The Netherlands, November 2 /PRNewswire/ -- InteRNA Technologies B.V. and the Dana-Farber Cancer Institute
(Boston, USA) have entered into a research agreement to develop microRNA...
Cambodia: World AIDS Day HIV Campaign, 'Testing Millions,' to Again Launch During Cambodia's National Water Festival
31st October 2009 PHNOM PENH, Cambodia, October 31 /PRNewswire/ -- As part of an ambitious global effort to test several million people for
HIV in observance of the Testing Millions...
/C O R R E C T I O N -- CeloNova BioSciences, Inc./
31st October 2009 NEWNAN, Georgia, October 31 /PRNewswire/ -- In the news release, French Physicians to Conduct 2000-Patient Study of
CATANIA(TM) Coronary Stent, issued Oct. 30, 2009, by CeloNova
BioSciences, Inc.,...
CeloNova First to Produce Super-Sized Embolic Microsphere
30th October 2009 NEWNAN, Georgia, October 30 /PRNewswire/ -- CeloNova BioSciences today announced that the company is submitting to
its European Notified Body a request for approval of its new, lime green,
2800...
French Physicians to Conduct 2000-Patient Study of CATANIA(TM) Coronary Stent
30th October 2009 NEWNAN, Georgia, October 30 /PRNewswire/ -- Physicians at more than 40 centers in France have joined a study of the
CATANIA(TM) Coronary Stent with NanoThin Polyzene(R)-F manufactured by
CeloNova...
HOYA Announces Second Quarter Financial Results
30th October 2009 TOKYO, October 30 /PRNewswire/ -- HOYA Corporation today announced financial results for the second quarter
ended September 30, 2009. Net sales were 106.8 billion yen for the quarter, a
16.8%...
London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
30th October 2009 LONDON, October 30 /PRNewswire/ -- London Genetics Limited, an expert in the use of
pharmacogenetics in clinical drug discovery and development, has entered an
intensive partnering programme...
Asklepios Clinics Hamburg Cooperate With the Internationally Leading Healthcare Company Bupa International
30th October 2009 HAMBURG, Germany, October 30 /PRNewswire/ -- Asklepios fosters Hamburg as a location for health industry.
Bupa International, the world's leading expatriate health insurer, and
Asklepios Clinics...
Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business
30th October 2009 ARDEE, Ireland, October 30 /PRNewswire/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the
acquisition of The Procter & Gamble Company's global branded...
Shire Continues to Deliver Excellent Growth From Core Products
30th October 2009 DUBLIN, October 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company, announces results for the three months to
September 30, 2009.
PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
30th October 2009 RALEIGH, North Carolina, October 30 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces
that its experts will present at a session during the 8th Annual...
CCBR-SYNARC Expands Electronic Data Capture Capabilities
30th October 2009 SAN FRANCISCO, October 30 /PRNewswire/ -- CCBR-SYNARC, the world's leading provider of medical image analysis,
biochemical marker, and clinical research center services to the
pharmaceutical and...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
